Javascript must be enabled to continue!
Extensive Limb Lengthening for Achondroplasia and Hypochondroplasia
View through CrossRef
Extensive limb lengthening (ELL) was completed in 75 patients: 66 achondroplasia and 9 hypochondroplasia. The average lengthening was 27cm for achondroplasia (12-40cm) and 17cm for hypochondroplasia (range 10-25cm). There were 48 females and 27 males. Lengthening was done either by 2-segment (14 patients; both tibias and/or both femurs) or by serial 4-segment lengthenings (64 patients; both femurs and tibias same time). Most patients also had bilateral humeral lengthening. Lengthenings were either juvenile-onset (31), adolescent-onset (38) or adult-onset (6). The average age at final follow-up was 26 years old (range 17-43 years). There were few permanent sequelae of complications. The most serious was one paraparesis. All patients returned to activities of normal living and only one was made worse by the surgery (paraparesis). This is the first study to show that ELL can lead to increase of height into the normal height range. Previous studies showed mean increases of height of up to 20cm, while this study consistently showed an average increase of 30 cm (range 15-40cm) for juvenile-onset and increase of 26cm (range 15-30cm) for adolescent-onset. This results in lower normal height at skeletal maturity for males and females. The adult-onset had a mean increase of 16.8 (range 12-22cm). This long-term follow-up study shows ELL can be done safely even with large lengthenings and that 4-segment lengthening may offer advantages over 2-segment lengthening. While the majority of cases were performed using external fixation, implantable limb lengthening promises to be an excellent alternative and perhaps an improvement.
Title: Extensive Limb Lengthening for Achondroplasia and Hypochondroplasia
Description:
Extensive limb lengthening (ELL) was completed in 75 patients: 66 achondroplasia and 9 hypochondroplasia.
The average lengthening was 27cm for achondroplasia (12-40cm) and 17cm for hypochondroplasia (range 10-25cm).
There were 48 females and 27 males.
Lengthening was done either by 2-segment (14 patients; both tibias and/or both femurs) or by serial 4-segment lengthenings (64 patients; both femurs and tibias same time).
Most patients also had bilateral humeral lengthening.
Lengthenings were either juvenile-onset (31), adolescent-onset (38) or adult-onset (6).
The average age at final follow-up was 26 years old (range 17-43 years).
There were few permanent sequelae of complications.
The most serious was one paraparesis.
All patients returned to activities of normal living and only one was made worse by the surgery (paraparesis).
This is the first study to show that ELL can lead to increase of height into the normal height range.
Previous studies showed mean increases of height of up to 20cm, while this study consistently showed an average increase of 30 cm (range 15-40cm) for juvenile-onset and increase of 26cm (range 15-30cm) for adolescent-onset.
This results in lower normal height at skeletal maturity for males and females.
The adult-onset had a mean increase of 16.
8 (range 12-22cm).
This long-term follow-up study shows ELL can be done safely even with large lengthenings and that 4-segment lengthening may offer advantages over 2-segment lengthening.
While the majority of cases were performed using external fixation, implantable limb lengthening promises to be an excellent alternative and perhaps an improvement.
Related Results
Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies
Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies
Background:
Achondroplasia is the most common short-limbed skeletal dysplasia resulting from gain-of-function pathogenic variants in fibroblast growth factor re...
Efficacy and safety of limb lengthening in achondroplasia: A systematic review and meta-analysis
Efficacy and safety of limb lengthening in achondroplasia: A systematic review and meta-analysis
Abstract
Purpose
To systematically review the efficacy, safety, and outcomes of limb lengthening procedures in patients w...
Quality of life in adults with achondroplasia in the United States
Quality of life in adults with achondroplasia in the United States
AbstractStudies examining quality of life (QoL) in adults with achondroplasia are limited. We report on QoL and psychiatric illness diagnoses in a modern cohort of adults with acho...
An overview of the International Consensus Statement on achondroplasia
An overview of the International Consensus Statement on achondroplasia
Abstract
Achondroplasia is the most common form of short-limbed short stature of genetic origin. Most people with achondroplasia live fully independent, productiv...
Body image and perception among adults with and without phantom limb pain
Body image and perception among adults with and without phantom limb pain
AbstractBackgroundFollowing lower‐limb amputation, phantom limb pain (i.e., pain perceived as coming from the amputated portion of the limb) is common. Phantom limb pain may be ass...
Achondroplasia with seronegative spondyloarthropathy resulting in recurrent spinal stenosis : A case report
Achondroplasia with seronegative spondyloarthropathy resulting in recurrent spinal stenosis : A case report
Background:
Achondroplasia is an autosomal dominant condition caused by the G380 mutation of the gene encoding fibroblast growth factor receptor 3 on chromosome 4P. The classical ...
T1-T12 and T1-S1 Lengths at Maturity in Patients With Skeletal Dysplasia
T1-T12 and T1-S1 Lengths at Maturity in Patients With Skeletal Dysplasia
Background:
Growing-spine surgery aims to promote thoracic growth in skeletally immature patients by achieving adequate T1-T12 length. Surgical decision-making ...
FGFR
3 Mutations and Medial Temporal Lobe Dysgenesis Lobe Dysgenesis
FGFR
3 Mutations and Medial Temporal Lobe Dysgenesis Lobe Dysgenesis
The authors describe a child who has hypochondroplasia due to an N540K mutation and who has medial temporal lobe dysgenesis. This association has been reported only twice before. F...

